Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Neurology. 2020 Aug 25;95(8):e1041-e1051. doi: 10.1212/WNL.0000000000010135. Epub 2020 Jul 7.
Neurology. 2020.
PMID: 32636328